l 670596 has been researched along with hydrazine in 1 studies
Studies (l 670596) | Trials (l 670596) | Recent Studies (post-2010) (l 670596) | Studies (hydrazine) | Trials (hydrazine) | Recent Studies (post-2010) (hydrazine) |
---|---|---|---|---|---|
21 | 0 | 0 | 12,034 | 330 | 3,193 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagchus, WM; Bresnahan, BA; Lianos, EA; Roman, RJ | 1 |
1 other study(ies) available for l 670596 and hydrazine
Article | Year |
---|---|
Mesangial cell immune injury: effects of thromboxane receptor antagonism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Antilymphocyte Serum; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Eicosanoids; Fatty Acids, Unsaturated; Glomerular Filtration Rate; Glomerular Mesangium; Hydrazines; Male; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2 | 1991 |